Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. RXRX
RXRX logo

RXRX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

RXRX News

Recursion Pharmaceuticals Faces Major Challenges Ahead

3d agoFool

Recursion Pharmaceuticals Leverages AI to Accelerate R&D

3d agoNASDAQ.COM

PacBio Appoints New Board Member

6d agoGlobenewswire

PacBio Appoints New Board Member

6d agoNewsfilter

PACBIO NAMES CHRIS GIBSON TO ITS BOARD OF DIRECTORS

6d agomoomoo

Recursion Pharmaceuticals Q4 2025 Earnings Call Insights

Feb 25 2026seekingalpha

Recursion Pharmaceuticals Q4 Earnings Exceed Expectations

Feb 25 2026seekingalpha

Recursion Pharmaceuticals Stock Surges After Strong Earnings Report

Feb 25 2026Benzinga

RXRX Events

03/05 08:50
Klarna Group Borrow Rate Increases to 31.14%
Latest data shows the largest indicative borrow rate increases among liquid option names include: Klarna Group PLC (KLAR) 31.14% +0.99, MSOX ETF (MSOX) 17.62% +0.72, Beyond Meat (BYND) 31.30% +0.59, PROSHARES ULTRA BITCOIN ETF (BITU) 3.88% +0.40, Plains GP Holdings (PAGP) 1.12% +0.37, Rezolve AI Ltd (RZLV) 2.46% +0.34, Aurora Cannabis (ACB) 11.33% +0.34, Kodiak AI, Inc. Common Stock (KDK) 43.37% +0.32, T-REX 2X LONG NVIDIA DAILY (NVDX) 12.47% +0.23, and Recursion Pharmaceuticals (RXRX) 1.31% +0.23.
03/05 08:50
PacBio Appoints Dr. Christopher Gibson to Board of Directors
PacBio (PACB) announced the appointment of Christopher Gibson, Ph.D., to PacBio's Board of Directors. Dr. Gibson is the co-founder and Chairman of the Board of Directors of Recursion (RXRX).

RXRX Monitor News

Recursion Pharmaceuticals Reports Strong Q4 Earnings, Shares Surge

Feb 25 2026

Recursion Pharmaceuticals Faces Pressure After Nvidia Exits Investment

Feb 19 2026

Recursion Pharmaceuticals Shares Drop After Nvidia Exits Stake

Feb 18 2026

Recursion Pharmaceuticals benefits from AI investment interest

Feb 06 2026

OpenAI explores biotech investments, highlighting Recursion's AI role

Feb 05 2026

Recursion Pharmaceuticals Faces Challenges Amid Stock Decline

Feb 04 2026

Recursion Pharmaceuticals Faces Challenges Amid Stock Decline

Feb 03 2026

Recursion Pharmaceuticals Faces High-Risk Profile Amid AI Development Challenges

Jan 22 2026

RXRX Earnings Analysis

No Data

No Data

People Also Watch